Table of Contents Table of Contents
Previous Page  295 / 1082 Next Page
Information
Show Menu
Previous Page 295 / 1082 Next Page
Page Background

S282

ESTRO 36 2017

_______________________________________________________________________________________________

Purpose or Objective

IROC Houston’s head and neck phantom has been used to

verify IMRT dose delivery for over a decade. While the

passing rate has seen gradual improvement, at present

more than 10% of institution’s that irradiate this phantom

still fail to meet the generous acceptability criteria. This

study explores the causes of these failures.

Material and Methods

To pass the head and neck phantom, the TPS-calculated

dose must agree within 7% with TLD measurement at 6

assessed locations in two PTVs. Two film planes must show

>85% of pixels passing a 7%/4mm gamma criterion. Failed

irradiations over the past year were evaluated

qualitatively for the cause of the failure: positioning

errors, systematic dosimetric errors, and other errors.

Based on the finding that most errors were systematic

dosimetric errors, further quantitative exploration was

done. Potential errors in institutional TPS beam models

were evaluated using an independent recalculation of the

phantom’s treatment plan. This was done using

“reference” beam models constructed from aggregated

IROC Houston measurements for different classes of

accelerator that were developed in Mobius 3D. 259

phantom plans were recalculated with these models.

Results

On qualitative evaluation, only 13% of failures were

attributed to localization errors, 18% were other non-

systematic errors, and the vast majority, 69%, were

systematic dosimetric errors: the dose distribution had the

right shape and was in the right place, but it was the

wrong magnitude. The independent recalculation of 259

phantom plans showed many cases where our reference

model was less accurate than the institution, but a

shocking number of cases where our recalculation was

more accurate, both significantly (based on a 2-sided t-

test with a failure detection rate correction applied), and

substantially (>2% average improvement across the 6 TLD).

The independent recalculation was significantly and

substantial better than the institution’s calculation in 18%

of all cases, and in 68% of cases where the institution

failed the phantom.

Conclusion

Failures of the IROC Houston IMRT phantom

overwhelmingly indicated a deficiency in the beam model.

This is concerning because this beam model is applied to

all patients, suggesting suboptimal treatment at nearly 1

in 5 radiotherapy facilities. It also indicates that physicists

should increase attention to beam modeling.

OC-0537 A remote EPID-based dosimetric auditing

method for VMAT delivery using a digital phantom

concept

P. Greer

1

, K. Legge

2

, N. Miri

2

, P. Vial

3

, T. Fuangrod

1

, J.

Lehmann

1

1

Calvary Mater Newcastle Hospital, Department of

Medical Physics, Newcastle, Australia

2

University of Newcastle, School of Physical and

Mathematical Sciences, Newcastle, Australia

3

Liverpool Hospital, Radiation Oncology, Sydney,

Australia

Purpose or Objective

Current methods to perform dosimetric audits for

participation in clinical trials are expensive and time-

consuming with high failure rates. Currently nearly 2/3 of

trial centres in Australia/New Zealand have not had an

independent VMAT dosimetric audit. The aim of this work

is to develop an inexpensive new method for remote

dosimetric VMAT auditing.

Material and Methods

Remote centres are provided with CT datasets and

planning guidelines to produce trial VMAT plans for a head

and neck and a post-prostatectomy treatment. The plans

are transferred in the treatment planning system (TPS) to

two digital water equivalent phantoms, one cylindrical (20

cm diameter) and one flat phantom. EPID cine images are

then acquired during the VMAT delivery to the EPID panel

in air. The cine images are backprojected to 3D dose in

the digital cylindrical phantom using an established

conversion method. This dose is then compared to TPS

dose at a central site. Individual 2D arc doses (with gantry

angles collapsed to zero in the TPS) are compared to EPID

derived dose at 10 cm depth in the flat phantom. For

Varian systems EPID images are obtained for Clinac

systems using cine imaging mode and for Truebeam

systems using image processing service which stores

individual cumulative frames. Both of these systems store

the gantry angle for the image in the header. For Elekta

systems the service XIS software was used as the clinical

cine mode normalises every image. This software acquires

individual frames without a gantry angle. Three methods

for gantry angle measurement were investigated, an

inclinometer, a video-based method, and the machine

iCom log files. The video-based method uses a printed

green arrow attached to the gantry, with a mobile phone

video recording during delivery. Colour detection and

image processing were used to determine the angle in

each movie frame.

Results

To date six Varian centres have been fully analysed. The

3D gamma comparison results (3%,3mm for >10% of global

maximum dose) were greater than 95% pass-rate for five

centres and 93% for the one centre. For the 2D individual

arcs all results were greater than 95% pass-rate for

3%,2mm criteria. Three Elekta centres have had

preliminary investigations. Gantry angle comparisons show

that the video method is comparable to the inclinometer

and is easy to perform using only a printed piece of paper

and mobile phone. Challenges for the method include

synchronisation of the angle measurement and the EPID

frames, and difficulty of use of the XIS software.

Figure 1. Comparison of gantry angles recorded for Elekta

system, inclinometer (NG360), iCom log file and mobile

phone method (insert)

Figure 2. Comparison of EPID derived dose and TPS dose

calculation for a Varian Truebeam system (sagittal dose

plane)